Wellcome Diagnostics (WD) were evaluated by using 289 randomly selected serum samples from a high-risk population and 53 serum samples likely to produce false-positive results. The radioimmunoprecipitation assay was used as the reference test. Sensitivities ranged from 96.51% (ODSI, WD) to 97.67% (ENI, GSC, OTI). Sera showing antibodies to viral glycoproteins only produced the false-negative results. Specificities ranged from 99.6% (ENI, GSC, ODSI, OTI) to 100% (WD). False-positive results were obtained with sera from patients with autoimmune disease or Epstein-Barr virus infection. Only results from GSC and OTI kits were distributed in two compact clusters well segregated on either side of the cutoff point. ODSI and GSC kits had the best intralot reproducibility. The GSC kit had the best interlot reproducibility. Cutoff values for ODSI and GSC kits were the least variable. Intraplate repeatability was good for all kits. Sample localization was not an important source of variability. Our results do not point out one outstanding kit among the five evaluated. However, the GSC kit showed the best overall results.
Anti-human immunodeficiency virus (HIV) enzyme-linked immunosorbent assays (ELISAs), first introduced in 1985 (12) , are inexpensive and easy to use for mass screening compared with the radioimmunoprecipitation assay (RIPA) (1), Western blotting (immunoblotting), and immunofluorescence (IFA) (2) . However anti-HIV ELISAs must be sensitive enough to detect all anti-HIV-positive individuals and as specific as possible to reduce the cost generated by confirmatory tests.
In the province of Quebec, hospitals offering HIV screening use the same type of equipment (ELISA Processor II; Calbiochem-Behring) and the same commercial ELISA anti-HIV kit to control expenses and to standardize the quality of testing. Since several kits are said to be compatible with the ELISA Processor II, an evaluation was carried out to determine the most suitable kit.
Five anti-HIV ELISA commercial kits (versions available during the first trimester of 1987) were evaluated by using current sera from the high-risk population screened in our hospitals. The RIPA was selected as the reference technique because it is more sensitive than most Western blot assays for the detection of antibodies to HIV glycoproteins (5) . The relative performance of each kit compared with the RIPA, its predictive value, and its reliability were determined. Finally, the ease of use was evaluated by three experienced technologists.
MATERIALS AND METHODS
Serum samples. A new frozen sample of coded serum was used for each test performed. The number of randomly selected serum samples was determined to provide the statistical power of 95% probability of finding significant * Corresponding author. (Table 2) . Tests were carried out with the ELISA Processor Il with the agreement of each of the kit suppliers. They were performed and interpreted according to the manufacturers' instructions. Sera were not heat inactivated before testing (12) . The ratio of the optical density to the cutoff value (R ratio) (ENI, GSC, ODSI, OTI) or the inverse ratio (WD) was used to classify the results as negative (R < 0.6), high negative (0.6 c R < 1.0), low positive (1.0 < R < 3.0), moderate positive (3.0 c R < 6.0), high positive (R > 6.0), or and lysed was used as the antigen (final concentration, 2.5 x 104 immunoprecipitable cpm per 50 ,il). Sera were considered positive when reactivity to the HIV glycoproteins was detected; they were negative when no viral polypeptide was precipitated.
RIPA-positive sera were titrated by IFA by using lymphadenopathy-associated virus type 1-infected MOLT4-T4 cells and fluorescein isothiocyanate-conjugated [F(ab')2] anti-human immunoglobulin G. Sera were classified as low positive (titer < 800), positive (800 c titer s 1,600), or high positive (titer > 1,600).
Study design. The 342 serum samples (Table 1) tested twice on 2 different days with microdilution plates from the same lot were used to evaluate the sensitivity, specificity, efficiency, predictive value, and intralot reproducibility (between-run precision) (17) .
The interlot reproducibility and the repeatability (withinrun precision) were evaluated by using a panel of 24 reference sera titrated by IFA (8 negative, 8 low positive, 8 high positive). They were tested six times on two microdilution plates from three different lots. One lot was tested per day by the same person in the same experitnental conditions. The plate loading pattern also allowed for the evaluation of edge effect (13) .
The ease of use of each kit was analyzed by the following criteria: clarity of the user's manual, number and simplicity of the steps, time to process one plate, and potential causes for errors.
Data analysis. Result status (true-or false-positive, true-or false-negative) was determined by using a 2 x 2 table (18) with the RIPA as the reference test. Sensitivity, specificity, efficiency, and predictive value were computed with the usual formulas (6, 16 is equal to 1 (optical density equal to the cutoff value; log1o 1 = 0).
The vertical axis shows the number of results obtained for each interval of R ratio. mined for each kit by using the mean R ratio of the four repeats for each serum (Fig. 1) .
Two intralot qualitative reproducibility parameters were computed. Status reproducibility indicates the percentage of sera yielding the same result (positive or negative) on four repeats. Class reproducibility represents the percentage of sera having four repeats within the same class as determined by the value of the R ratio (see above). Three intralot quantitative reproducibility parameters were computed. The interplate correlation (Pearson's coefficient of correlation [4] ) indicates the agreement between paired results on two The interlot reproducibility was evaluated by using the pooled standard deviation (8) and the coefficient of variation. The interlot standard deviation is an assessment of the absolute variation due to differences between lots. A small value indicates a good interlot reproducibility. The interlot variability is computed by subtracting the average coefficient of variation of the lots from the coefficient of variation of the kit (computed from the pooled standard deviation). It indicates the relative importance of the interlot standard deviation in relation to the mean value of all the results within a kit for a given sample.
The intraplate coefficient of correlation was used to evaluate the repeatability of the kits. It represents the average coefficient of correlation between paired results on the same plate (two repeats on the same plate, same testing day, single person using the same sample).
The edge effect (13) was computed by subtracting the intraplate variability of repeats of sera located at the center of the plate from the variability of repeats of the same sera located on the edge of the plate.
Computer analysis was performed by using a relational database management system (REFLEX 1.1; Borland International/Analytica Inc.) interfaced with electronic spreadsheet templates (LOTUS 1-2-3 1A; LOTUS Development Corp.), both softwares running on an IBM-PC/XT microcomputer.
RESULTS
Performance of the kits. Sensitivities, specificities, efficiencies, and predictive values are given in Table 3 (Fig. 1) . The distribution of results from ENI, ODSI, and WD kits was less segregated.
Reliabiity of the kits. The intralot reproducibility parameters are given in Table 4 . The interlot reproducibility parameters are given in Table 5 The preparation of the different buffers was identical. The buffers were color coded, and reagent volumes added to each well were constant, thereby decreasing the risk of errors. The four remaining kits were also relatively easy to use. However, each of them lacked some of the features that made the GSC kit easier to use.
DISCUSSION
The highest sensitivity was obtained with the ENI, GSC, and OTI kits (97.67%). The false-negative results were obtained with sera showing weak RIPA reactivity to HIV (10) . These antigens, present in the H9 cell line, are known to react with antibodies produced in autoimmune diseases such as lupus erythematosus (11) . The false-positive reactions obtained with ENI, OTI, and ODSI kits which use virus grown in H9 cells (Table 2 ) may be due to the presence of antibodies reacting with contaminating cellular antigens. False-positive reactions with sera from patients with EBV infection have been previously reported (12) . Since antibody to lymphocytes may be induced during EBV infection (9) , these may react with cellular antigenic determinants present in the wells.
Reactive and nonreactive ELISA values should be distributed in two compact clusters well segregated on either side of the cutoff point to decrease the risk of misinterpretation due to overlapping (7) . Two kits (GSC, OTI) had this type of distribution, indicating that they should produce fewer misinterpreted results due to R ratios in the high-negative/ low-positive region (0.6 < R < 3). Most of the negative results from the WD kit are in the high-negative region (Fig.  1) ; this is characteristic of a competitive assay.
The ODSI and GSC kits had the best intralot reproducibility, and the GSC kit had the best interlot reproducibility.
The cutoff values for these two kits were also the least variable (<4%). The ENI, GSC, and OTI kits had the best repeatability.
The variabilities due to the edge effect were small, indicating that sera localization was not an important source of variability in our experimental conditions.
Errors or invalidated tests due to technical difficulties are rare when using a well designed, easy to use kit. Thereby the cost of using such a kit is kept to a minimum. Our observations, even if partly subjective, indicate that the GSC kit was the easiest to use in our experimental conditions.
Our results do not point out one outstanding kit among the five kits evaluated. However, the GSC kit had the best overall results when performance, reliability, and ease of use were taken into account.
